 Predictive Oncology Inc is blazing a path as a company that can operate through the fullness of the RD spectrum of pharma and speed up new cancer treatments. The Minneapolis, Minnesota-based company shared initial results in December 2021, showing that its flagship drug discovery platform powered by both artificial intelligence AI and large patient datasets, can predict cancer drug responses with great accuracy. 